Difference between revisions of "Part:BBa K4165215"
Omnia Alaa11 (Talk | contribs) |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 4: | Line 4: | ||
Fusion protein consists of Tau binding peptide (TD28) for tau targeting and Coh2 protein [BBa_K4165003] that bind to Docs [BBa_K3396000] to form the protac system. | Fusion protein consists of Tau binding peptide (TD28) for tau targeting and Coh2 protein [BBa_K4165003] that bind to Docs [BBa_K3396000] to form the protac system. | ||
| − | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
| Line 11: | Line 10: | ||
<!-- --> | <!-- --> | ||
| − | <span class='h3bb'>Sequence and Features</span> | + | ===<span class='h3bb'>Sequence and Features</span>=== |
<partinfo>BBa_K4165215 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165215 SequenceAndFeatures</partinfo> | ||
Latest revision as of 08:37, 13 October 2022
Coh2 linked with tau binding peptide (TD28) & (G4S)3 linker
Fusion protein consists of Tau binding peptide (TD28) for tau targeting and Coh2 protein [BBa_K4165003] that bind to Docs [BBa_K3396000] to form the protac system.
Usage and Biology
Protac system is known to be a promising one for targeting and signaling many diseases and biological application so according to our project aim, we introduced this fusion protein with different linker length and tau binding peptide to be a target for degradation of Tau aggregation in our updated protac version system "Snitch system". Furthermore, that can be validated by wet-lab results by in vitro or in vivo testing.
Sequence and Features
Assembly Compatibility:
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 469
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 469
- 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 469
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 469
- 1000COMPATIBLE WITH RFC[1000]